+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transplantation - Global Strategic Business Report

  • PDF Icon

    Report

  • 451 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 5141507
The global market for Transplantation was estimated at US$11.4 Billion in 2025 and is projected to reach US$19.3 Billion by 2032, growing at a CAGR of 7.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Transplantation Market - Key Trends & Drivers Summarized

What Is Transplantation and Why Is It Vital?

Transplantation is a medical procedure that involves transferring organs, tissues, or cells from a donor to a recipient to restore function in a damaged or failing body part. Common types of transplants include kidney, liver, heart, lung, and bone marrow transplants. Transplantation is vital for saving lives and improving the quality of life for patients with end-stage organ failure and certain diseases. The success of transplantation relies on matching donors and recipients, managing immune responses, and ensuring long-term graft survival. Advances in transplantation techniques and immunosuppressive therapies have significantly improved transplant outcomes, making it a critical component of modern medicine.

How Have Technological Advances Impacted the Market?

Technological advances have profoundly impacted the transplantation market. Innovations in surgical techniques, such as minimally invasive and robotic-assisted surgeries, have improved the precision and outcomes of transplant procedures. The development of advanced immunosuppressive drugs has enhanced the management of transplant rejection and improved graft survival rates. Advances in organ preservation and transportation technologies, such as machine perfusion and cold storage solutions, have extended the viability of donor organs, increasing the success rates of transplants. Additionally, regenerative medicine and stem cell research have opened new possibilities for creating bioengineered organs and tissues, addressing the shortage of donor organs. These technological advancements have expanded the scope and effectiveness of transplantation, driving market growth.

Who Are the Key Stakeholders and What Are Their Needs?

The key stakeholders in the transplantation market include transplant centers, hospitals, organ procurement organizations, pharmaceutical companies, and patients. Transplant centers and hospitals perform transplant procedures and provide post-transplant care, requiring access to high-quality donor organs, advanced surgical tools, and effective immunosuppressive therapies. Organ procurement organizations coordinate the donation and distribution of organs, seeking efficient and reliable organ preservation and transportation solutions. Pharmaceutical companies develop immunosuppressive drugs and other therapies to manage transplant rejection and improve outcomes, requiring robust clinical research and development capabilities. Patients rely on successful transplantation to restore their health and quality of life, seeking access to timely and effective transplant services. Each stakeholder group demands innovative and effective solutions to address the complex challenges of transplantation.

What Is Driving Growth in the Transplantation Market?

The growth in the transplantation market is driven by several factors, including the increasing prevalence of organ failure, advancements in transplantation techniques, and the rising demand for organ transplants. The growing incidence of chronic diseases, such as diabetes, cardiovascular diseases, and liver cirrhosis, has led to an increase in organ failures, driving the demand for transplantation. Advancements in transplantation techniques, such as improved surgical methods and immunosuppressive therapies, have enhanced transplant success rates and expanded the pool of eligible recipients. The rising demand for organ transplants, driven by increasing awareness and acceptance of organ donation, has further fueled market growth. Additionally, government initiatives and funding for transplant programs and research have supported the expansion and development of the transplantation market.

Report Scope

The report analyzes the Transplantation market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Product (Tissue Product, Immunosuppressive Drugs Product, Preservation Solutions & Systems Product); Application (Organ Transplantation Application, Tissue Transplantation Application); End-Use (Hospitals End-Use, Transplant Centers End-Use, Ambulatory Surgery Centers End-Use, Research & Academic Institutes End-Use)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Tissue Product segment, which is expected to reach US$7.5 Billion by 2032 with a CAGR of a 5.9%. The Immunosuppressive Drugs Product segment is also set to grow at 9.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $3.5 Billion in 2025, and China, forecasted to grow at an impressive 12.0% CAGR to reach $5.0 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Transplantation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Transplantation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Transplantation Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Inc., Acelity LP, Inc., Avioq, Inc., AxoGen, Inc., BD Biosciences and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Transplantation market report include:

  • Abbott Laboratories, Inc.
  • Acelity LP, Inc.
  • Avioq, Inc.
  • AxoGen, Inc.
  • BD Biosciences
  • BioLife Solutions Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • Carmat SA
  • Chronix Biomedical
  • Dr. Franz Kohler Chemie GmbH
  • F. Hoffmann-La Roche AG
  • GenDx
  • Histogenics Corporation
  • Illumina, Inc.
  • Luminex Corporation
  • Medipex Limited
  • Miromatrix Medical Inc.
  • Nano Dimension Ltd.
  • Organovo Holdings, Inc.
  • Ortho Clinical Diagnostics
  • Oxford Immunotec Global PLC
  • Pacific Biosciences of California, Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Qiagen NV
  • Siemens Healthineers
  • SynCardia
  • Thermo Fisher Scientific, Inc.
  • Transplant Biomedicals S.L.
  • XVIVO Perfusion AB

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 32,266 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Transplantation - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Incidence of Chronic Diseases
  • Advancements in Surgical Techniques
  • Growth in Organ Donation Awareness
  • Development of Organ Preservation Technologies
  • Rising Adoption of Minimally Invasive Surgeries
  • Expansion of Transplant Centers and Facilities
  • Innovations in Tissue Engineering and Regenerative Medicine
  • Increasing Funding for Transplant Research
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Transplantation Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Tissue Product by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Tissue Product by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Tissue Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Immunosuppressive Drugs Product by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Immunosuppressive Drugs Product by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Immunosuppressive Drugs Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Preservation Solutions & Systems Product by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Preservation Solutions & Systems Product by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Preservation Solutions & Systems Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Organ Transplantation Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Organ Transplantation Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Organ Transplantation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Tissue Transplantation Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Tissue Transplantation Application by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Tissue Transplantation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Transplant Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Transplant Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Transplant Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAIN
RUSSIA
REST OF EUROPE
AUSTRALIA
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
  • Transplantation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories, Inc.
  • Acelity LP, Inc.
  • Avioq, Inc.
  • AxoGen, Inc.
  • BD Biosciences
  • BioLife Solutions Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • Carmat SA
  • Chronix Biomedical
  • Dr. Franz Kohler Chemie GmbH
  • F. Hoffmann-La Roche AG
  • GenDx
  • Histogenics Corporation
  • Illumina, Inc.
  • Luminex Corporation
  • Medipex Limited
  • Miromatrix Medical Inc.
  • Nano Dimension Ltd.
  • Organovo Holdings, Inc.
  • Ortho Clinical Diagnostics
  • Oxford Immunotec Global PLC
  • Pacific Biosciences of California, Inc.
  • Pandorum Technologies Pvt. Ltd.
  • Qiagen NV
  • Siemens Healthineers
  • SynCardia
  • Thermo Fisher Scientific, Inc.
  • Transplant Biomedicals S.L.
  • XVIVO Perfusion AB

Table Information